SAN DIEGO, CA--(Marketwire - September 23, 2008) - Lpath, Inc. (OTCBB: LPTN), the category leader in therapeutic agents against bioactive lipids, has appointed John Bender, Pharm.D., as senior vice president of research and development effective September 22, 2008. Bender succeeds William Garland, Ph.D., who will continue to serve in an advisory capacity during the transition.
